article thumbnail

Association of typical atrial flutter and cavotricuspid isthmus ablation on clinical recurrence after cryoballoon ablation for atrial fibrillation

Frontiers in Cardiovascular Medicine

Typical atrial flutter commonly occurs in patients with atrial fibrillation (AF). Limited information exists regarding the effects of concurrent atrial flutter on the long-term outcomes of rhythm control. The data were obtained from a multicenter registry of cryoballoon ablation for AF ( n  = 2,689).

article thumbnail

Long-term outcomes after catheter ablation for idiopathic atypical atrial flutter

HeartRhythm

Idiopathic atypical (non-cavotricupid isthmus [CTI]-dependent) atrial flutter (IAAFL) may be seen in patients without structural heart disease and without previous cardiac surgery or ablation.

article thumbnail

Case Report: Epi-endocardial bridges in refractory cavotricuspid isthmus-dependent atrial flutter: technical analysis of epi-endocardial breakthrough

Frontiers in Cardiovascular Medicine

BackgroundTypical isthmus-dependent atrial flutter (AFL) is traditionally treated through radiofrequency (RF) ablation to create a bidirectional conduction block across the cavo-tricuspid isthmus (CTI) in the right atrium.

article thumbnail

PO-01-009 THE EFFECT OF CATHETER ABLATION OF TYPICAL ATRIAL FLUTTER ON ATRIAL REMODELLING AND VENTRICULAR FUNCTION

HeartRhythm

Cavo-tricuspid isthmus (CTI) dependent atrial flutter (AFL) is one of the most common atrial arrhythmias involving the right atrium (RA). Radiofrequency catheter ablation has been widely used as a therapy of choice and it is curative.

article thumbnail

PO-05-026 SENSITIVITY OF FIBROSIS THRESHOLD IN PATIENT-SPECIFIC COMPUTATIONAL MODELS OF ATYPICAL ATRIAL FLUTTER

HeartRhythm

Image-based patient-specific computational models have recently emerged as a tool to guide atypical atrial flutter (AAF) ablation. However, little is known about the sensitivity of these models to the selection of parameters.

article thumbnail

PO-05-111 CLINICAL OUTCOMES OF CATHETER ABLATION FOR ATRIAL FIBRILLATION, ATRIAL FLUTTER, AND ATRIAL TACHYCARDIA IN WILD-TYPE TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: A PROPOSED TREATMENT STRATEGY FOR CATHETER ABLATION IN EACH ARRHYTHMIA

HeartRhythm

Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) is often accompanied by atrial fibrillation (AF), atrial flutter (AFL), and atrial tachycardia (AT), which are difficult to control because beta-blockers and antiarrhythmic drugs can worsen heart failure (HF).

article thumbnail

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

DAIC

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. The company now anticipates U.S. Circulation.